References
- Asakura H, Ogawa H. COVID-19-associated coagulopathy and disseminated
intravascular coagulation. International Journal of Hematology.
2020:1-13.
- Arachchillage DR, Shi C, Saliu D, Kozman P, Mi E, Buti N, et al.,
editors. Efficacy Safety and of D-dimer, Weight, and Renal
Function-Adjusted Thromboprophylaxis in Patients with Coronavirus
Disease 2019 (COVID-19). Seminars in Thrombosis and Hemostasis; 2021:
Thieme Medical Publishers, Inc.
- Bhatia R, Srivastava MP. COVID-19 and stroke: Incidental, triggered or
causative. Annals of Indian Academy of Neurology. 2020;23(3):318.
- Canzano P, Brambilla M, Porro B, Cosentino N, Tortorici E, Vicini S,
et al. Platelet and endothelial activation as potential mechanisms
behind the thrombotic complications of COVID-19 patients. Basic to
Translational Science. 2021;6(3):202-18.
- Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological
and clinical characteristics of 99 cases of 2019 novel coronavirus
pneumonia in Wuhan, China: a descriptive study. The lancet.
2020;395(10223):507-13.
- Fruchter O, Yigla M, Kramer MR. D-dimer as a prognostic biomarker for
mortality in chronic obstructive pulmonary disease exacerbation. The
American journal of the medical sciences. 2015;349(1):29-35.
- Snijders D, Schoorl M, Schoorl M, Bartels PC, van der Werf TS, Boersma
WG. D-dimer levels in assessing severity and clinical outcome in
patients with community-acquired pneumonia. A secondary analysis of a
randomised clinical trial. European Journal of internal medicine.
2012;23(5):436-41.
- Tayman C, Tonbul A, Akca H, Bilici M. Mean platelet volume (MPV) may
simply predict the severity of sepsis in preterm infants. Clin Lab.
2014;60(7):1193-200.
- Manolis AS, Manolis TA, Manolis AA, Papatheou D, Melita H. COVID-19
infection: viral macro-and micro-vascular coagulopathy and
thromboembolism/prophylactic and therapeutic management. Journal of
Cardiovascular Pharmacology and Therapeutics. 2021;26(1):12-24.
- Yin S, Huang M, Li D, Tang N. Difference of coagulation features
between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2.
Journal of thrombosis and thrombolysis. 2020:1-4.
- Danzi GB, Loffi M, Galeazzi G, Gherbesi E. Acute pulmonary embolism
and COVID-19 pneumonia: a random association? European heart journal.
2020;41(19):1858-.
- Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features
of patients infected with 2019 novel coronavirus in Wuhan, China. The
lancet. 2020;395(10223):497-506.
- Zhong Q, Peng J. Mean platelet volume/platelet count ratio predicts
severe pneumonia of COVID‐19. Journal of clinical laboratory analysis.
2021;35(1):e23607.
- Lippi G, Henry BM, Favaloro EJ, editors. Mean Platelet Volume Predicts
Severe COVID-19 Illness. Seminars in Thrombosis and Hemostasis; 2021:
Thieme Medical Publishers, Inc.
- Guner Ozenen G, Sahbudak Bal Z, Umit Z, Bilen NM, Yildirim Arslan S,
Yurtseven A, et al. Demographic, clinical, and laboratory features of
COVID‐19 in children: The role of mean platelet volume in predicting
hospitalization and severity. Journal of Medical Virology.
2021;93(5):3227-37.
- Aktaş A, Sener K, Yılmaz N, Tunç M, Yolcu S. Is Mean Platelet Volume
Useful for Predicting the Prognosis of COVID-19 Diagnosed Patients?
Age. 2020;54(18,191):18,191.
- Mouhat B, Besutti M, Bouiller K, Grillet F, Monnin C, Ecarnot F, et
al. Elevated D-dimers and lack of anticoagulation predict PE in severe
COVID-19 patients. European Respiratory Journal. 2020;56(4).
- Song X, Ji J, Reva B, Joshi H, Calinawan AP, Mazumdar M, et al.
Post-anticoagulant D-dimer is a highly prognostic biomarker of
COVID-19 mortality. ERJ Open Research. 2021.
- Liu X, Li Z, Liu S, Chen Z, Zhao Z, Huang Y-y, et al. Therapeutic
effects of dipyridamole on COVID-19 patients with coagulation
dysfunction. MedRxiv. 2020.
- Guo L, Wei D, Zhang X, Wu Y, Li Q, Zhou M, et al. Clinical features
predicting mortality risk in patients with viral pneumonia: the
MuLBSTA score. Frontiers in microbiology. 2019;10:2752.
- Vizcaychipi MP, Shovlin CL, McCarthy A, Godfrey A, Patel S, Shah PL,
et al. Increase in COVID-19 inpatient survival following detection of
Thromboembolic and Cytokine storm risk from the point of admission to
hospital by a near real time Traffic-light System (TraCe-Tic). The
Brazilian Journal of Infectious Diseases. 2020;24(5):412-21.
- Wool GD, Miller JL. The impact of COVID-19 disease on platelets and
coagulation. Pathobiology. 2021;88(1):14-26.
- Wu Z, McGoogan JM. Characteristics of and important lessons from the
coronavirus disease 2019 (COVID-19) outbreak in China: summary of a
report of 72 314 cases from the Chinese Center for Disease Control and
Prevention. Jama. 2020;323(13):1239-42.
- Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and
risk factors for mortality of adult inpatients with COVID-19 in Wuhan,
China: a retrospective cohort study. The lancet.
2020;395(10229):1054-62.
- Zhang S, Liu Y, Wang X, Yang L, Li H, Wang Y, et al. SARS-CoV-2 binds
platelet ACE2 to enhance thrombosis in COVID-19. Journal of hematology
& oncology. 2020;13(1):1-22.
- Zhou P, Yang X-L, Wang X-G, Hu B, Zhang L, Zhang W, et al. A pneumonia
outbreak associated with a new coronavirus of probable bat origin.
nature. 2020;579(7798):270-3.
- Fan BE. Hematologic parameters in patients with COVID‐19 infection: a
reply. American journal of hematology. 2020.
- Arachchillage DR, Laffan M. Abnormal coagulation parameters are
associated with poor prognosis in patients with novel coronavirus
pneumonia. Journal of thrombosis and haemostasis. 2020;18(5):1233-4.
- Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical
characteristics of 138 hospitalized patients with 2019 novel
coronavirus–infected pneumonia in Wuhan, China. Jama.
2020;323(11):1061-9.